M.B.A., MIT Sloan School of Management; A.B., applied mathematics and economics, Harvard University
Summary of Experience
Mr. Weinstein specializes in the application of quantitative methods to real-world problems involving decision making, strategy, risk management, and litigation in a variety of sectors. His work in the health care sector includes building algorithms for real-time suspicious order monitoring of controlled substance distribution by manufacturers and wholesalers, as well as statistical assessments of controlled substance dispensing issues at the pharmacy and prescriber levels. He has also led the creation of flexible damages models for use in litigation matters involving the False Claims Act, the Anti-Kickback Statute, intellectual property, and controlled substance regulation. He has served as an expert witness, testifying in administrative proceedings before the Drug Enforcement Administration (DEA).
Mr. Weinstein has managed the analysis of large transaction-level and claims databases. He also has broad experience supporting leading academic experts, working with cross-functional client teams, and presenting analytical results to top executives and government officials, including those at the DEA, US Attorneys’ Offices, and state attorneys general. In his work at Analysis Group, Mr. Weinstein builds on his prior experience, which includes contributing to economics research on 401(k) savings behavior, forecasting consumer demand at Zipcar, and advising foundations and government agencies on how to track and interpret data.
Law 360, April 17, 2017